End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,370 KRW | 0.00% | +0.94% | -13.39% |
2023 | PharmGen Science, Inc.(KOSE:A004720) dropped from S&P Global BMI Index | CI |
2023 | PharmGen Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Business Summary
Number of employees: 250
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 150,931 | 100.0 % | 166,779 | 100.0 % | +10.50% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
99.5
%
| 150,065 | 99.4 % | 165,885 | 99.5 % | +10.54% |
Overseas
0.5
%
| 866 | 0.6 % | 894 | 0.5 % | +3.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hee-Deok Park
CEO | Chief Executive Officer | 56 | 27/19/27 |
Hye-Yeon Kim
CEO | Chief Executive Officer | 67 | - |
Nam-Hyun Ryu
BRD | Director/Board Member | 58 | - |
Seung-Yeol Lee
BRD | Director/Board Member | 44 | - |
Seo-In Kim
AUD | Comptroller/Controller/Auditor | 42 | 26/20/26 |
Hae-Doo Lee
PRN | Corporate Officer/Principal | 61 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Seung-Yeol Lee
BRD | Director/Board Member | 44 | - |
Hye-Yeon Kim
CEO | Chief Executive Officer | 67 | - |
Nam-Hyun Ryu
BRD | Director/Board Member | 58 | - |
Hee-Deok Park
CEO | Chief Executive Officer | 56 | 27/19/27 |
Dong-Hwa Yoon
BRD | Director/Board Member | 63 | - |
In-Ki Lee
BRD | Director/Board Member | 61 | 26/20/26 |
Kwang-Hae Lee
BRD | Director/Board Member | 52 | 26/20/26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,178,525 | 15,763,523 ( 86.72 %) | 41,910 ( 0.2305 %) | 86.72 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ACCESS BIO, INC. 25.22% | 9,171,729 | 25.22% | 50,823,485 $ |
PHARMGEN SCIENCE, INC. 0.23% | 41,910 | 0.23% | 175,579 $ |
Company contact information
PharmGen Science, Inc.
50 Pharmaceutical Ind. Complex 2-gil Hyangnam-myeon
18622, Hwaseong
+
http://www.pharmgenscience.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-13.39% | 71.36M | |
+18.67% | 43.74B | |
+21.99% | 22.26B | |
+16.41% | 14.9B | |
+9.03% | 13.39B | |
+40.48% | 12.12B | |
-9.64% | 6.92B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.41% | 5.47B |
- Stock Market
- Equities
- A004720 Stock
- Company PharmGen Science, Inc.